Search

Your search keyword '"Central nervous system depressants -- Research"' showing total 4 results
Start Over Descriptor "Central nervous system depressants -- Research" Publisher pr newswire association llc
4 results on '"Central nervous system depressants -- Research"'

1. Tris Pharma Reports Positive Topline Data from Clinical Study of Investigational Pain Therapy Cebranopadol Showing Significantly Less Potential for Abuse Versus Tramadol and Oxycodone

Subjects
Central nervous system depressants -- Research, Clinical trials -- Research, Oxycodone -- Research, Tramadol -- Research, Pain -- Care and treatment, Drug abuse -- Care and treatment -- Research, Business, News, opinion and commentary
Abstract

-- Study evaluating human abuse potential demonstrates that the likeability of cebranopadol administered orally in nondependent recreational opioid users was significantly less as compared to immediate release (IR) formulations of [...]

Published
2022

2. Egalet Announces ARYMO ER Data Published in Current Medical Research and Opinion Journal

Subjects
Morphine -- Research, Medical research, Medicine, Experimental, Central nervous system depressants -- Research, Pain -- Care and treatment, Business, News, opinion and commentary, Arymo ER (Medication)
Abstract

--Data help clinicians interpret abuse-deterrent studies-- WAYNE, Pa., Jan. 29, 2018 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ('Egalet'), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing [...]

Published
2018

3. Egalet Presented New Data at PAINWEEK Demonstrating Potential of ARYMO ER to Deter Opioid Abuse

Subjects
Morphine -- Research, Central nervous system depressants -- Research, Pain -- Care and treatment, Sulfates, Business, News, opinion and commentary, Arymo ER (Medication)
Abstract

--Additional Study Examined Reasons Why Opioid Abusers Progress to More Dangerous Routes of Administration Beyond Oral Abuse-- WAYNE, Pa., Sept. 8, 2017 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ('Egalet'), a [...]

Published
2017

4. Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by Pain Practice

Subjects
Central nervous system depressants -- Research, Oxycodone -- Research, Pain -- Care and treatment, Osteoarthritis -- Research, Nausea -- Research, Business, News, opinion and commentary
Abstract

RARITAN, N.J., July 19 /PRNewswire/ -- A Phase 3 open-label study, recently published online by Pain Practice , has compared tapentadol extended release (ER) tablets, an investigational pain medication, to [...]

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results